Cumberland Pharmaceuticals Stock Price on October 30, 2024
| CPIX Stock | USD 1.25 0.05 3.85% |
Below is the normalized historical share price chart for Cumberland Pharmaceuticals extending back to August 11, 2009. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Cumberland Pharmaceuticals stands at 1.25, as last reported on the 3rd of December, with the highest price reaching 1.37 and the lowest price hitting 1.20 during the day.
If you're considering investing in Cumberland Stock, it is important to understand the factors that can impact its price. At this stage we consider Cumberland Stock to be risky. Cumberland Pharmaceuticals secures Sharpe Ratio (or Efficiency) of 0.024, which signifies that the company had a 0.024% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Cumberland Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please confirm Cumberland Pharmaceuticals' Downside Deviation of 3.11, mean deviation of 2.27, and Risk Adjusted Performance of 0.0082 to double-check if the risk estimate we provide is consistent with the expected return of 0.0932%.
At this time, Cumberland Pharmaceuticals' Total Stockholder Equity is fairly stable compared to the past year. Liabilities And Stockholders Equity is likely to rise to about 88.1 M in 2024, whereas Common Stock Shares Outstanding is likely to drop slightly above 13.5 M in 2024. . Price To Free Cash Flows Ratio is likely to rise to 4.76 in 2024, whereas Price To Sales Ratio is likely to drop 0.61 in 2024. Cumberland Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 11th of August 2009 | 200 Day MA 1.4934 | 50 Day MA 1.2148 | Beta 0.219 |
Cumberland |
Sharpe Ratio = 0.024
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | CPIX | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.88 actual daily | 34 66% of assets are more volatile |
Expected Return
| 0.09 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average Cumberland Pharmaceuticals is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cumberland Pharmaceuticals by adding it to a well-diversified portfolio.
Price Book 0.7934 | Enterprise Value Ebitda 106.3191 | Price Sales 0.4963 | Shares Float 7.8 M | Wall Street Target Price 8.5 |
Cumberland Pharmaceuticals Main Headline on 30th of October 2024
Acquisition by Krogulski Kenneth of 309 shares of Cumberland... by Krogulski Kenneth
Filed transaction by Cumberland Pharmaceuticals Director. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Cumberland Pharmaceuticals Valuation on October 30, 2024
It is possible to determine the worth of Cumberland Pharmaceuticals on a given historical date. On October 30, 2024 Cumberland was worth 1.22 at the beginning of the trading date compared to the closed value of 1.19. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Cumberland Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Cumberland Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Cumberland Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Cumberland Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 1.22 | 1.25 | 1.22 | 1.24 | 18,441 | |
10/30/2024 | 1.22 | 1.33 | 1.18 | 1.19 | 46,437 |
| 1.18 | 1.21 | 1.11 | 1.12 | 206,794 |
| Backtest Cumberland Pharmaceuticals | | | Cumberland Pharmaceuticals History | | | Cumberland Pharmaceuticals Valuation | Previous | Next |
Cumberland Pharmaceuticals Trading Date Momentum on October 30, 2024
| On October 31 2024 Cumberland Pharmaceuticals was traded for 1.12 at the closing time. The top price for the day was 1.21 and the lowest listed price was 1.11 . The trading volume for the day was 206.8 K. The trading history from October 31, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 5.88% . The overall trading delta against the current closing price is 4.20% . |
Cumberland Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Cumberland Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Cumberland Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Cumberland financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Cumberland Pharmaceuticals Stock history
Cumberland Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Cumberland is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Cumberland Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Cumberland Pharmaceuticals stock prices may prove useful in developing a viable investing in Cumberland Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 14.3 M | 13.5 M | |
| Net Loss | -5 M | -4.8 M |
Cumberland Pharmaceuticals Quarterly Net Working Capital |
|
Cumberland Pharmaceuticals Stock Technical Analysis
Cumberland Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Cumberland Pharmaceuticals Period Price Range
Low | December 3, 2024
| High |
0.00 | 0.00 |
Cumberland Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Cumberland Pharmaceuticals December 3, 2024 Market Strength
Market strength indicators help investors to evaluate how Cumberland Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cumberland Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Cumberland Pharmaceuticals stock market strength indicators, traders can identify Cumberland Pharmaceuticals entry and exit signals to maximize returns
Cumberland Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Cumberland Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Cumberland Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Cumberland to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0082 | |||
| Jensen Alpha | (0.06) | |||
| Total Risk Alpha | (0.59) | |||
| Sortino Ratio | (0.04) | |||
| Treynor Ratio | (0.02) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Cumberland Stock Analysis
When running Cumberland Pharmaceuticals' price analysis, check to measure Cumberland Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cumberland Pharmaceuticals is operating at the current time. Most of Cumberland Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Cumberland Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cumberland Pharmaceuticals' price. Additionally, you may evaluate how the addition of Cumberland Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.